MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma

Pancreatic cancer is the fourth leading cause of cancer death in western countries with more than 100,000 new cases per year in Europe and a mortality rate higher than 90%. In this scenario, advanced therapies based on gene therapies are emerging, thanks to a better understanding of tumour architect...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Theranostics
Main Authors: Rossignoli, Filippo, Spano, Carlotta, Grisendi, Giulia, Foppiani, Elisabetta Manuela, Golinelli, Giulia, Mastrolia, Ilenia, Bestagno, Marco, Candini, Olivia, Petrachi, Tiziana, Recchia, Alessandra, Miselli, Francesca, Rovesti, Giulia, Orsi, Giulia, Veronesi, Elena, Medici, Gregorio, Petocchi, Benedetta, Pinelli, Massimo, Horwitz, Edwin M., Conte, Pierfranco, Dominici, Massimo
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2019
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6376176/
https://ncbi.nlm.nih.gov/pubmed/30809285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.27576
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares